Dr Reddys Share Price Live Updates: Dr. Reddy’s Laboratories ends trading at Rs 1230.0
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Profit by knowlytics
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Indian stock markets closed higher on Wednesday with marginal gains. The Iran-US conflict escalated, impacting global oil prices significantly. Investors face uncertainty due to geopolitical tensions and domestic economic factors. Rising inflation and monsoon deficiency pose challenges for the Indian economy. Experts advise remaining invested in fairly valued growth sector stocks.
Ace investor Mukul Agrawal trimmed his stake in J Kumar Infraprojects and is likely to have exited Surya Roshni during the June quarter, according to the latest shareholding disclosures. While he reduced his holding in the construction company, his name no longer appears among Surya Roshni’s key shareholders, indicating his stake has likely fallen below…
ICICI Prudential Life Insurance reported a twenty-eight percent net profit increase. Net premium income rose to nine thousand seven hundred forty-nine crore rupees. New business premium grew by twenty-one percent, and policy numbers also increased. Total revenue reached twenty-eight thousand three hundred ninety-five crore rupees. The company proposed changing its name to ICICI Life Insurance…
IBM shares rebounded nearly 2% in premarket trade after plunging 25% in their worst single-day fall in 58 years, wiping out nearly $70 billion in market value. The selloff was triggered by weaker-than-expected preliminary Q2 results and concerns that customers are shifting spending from IBM’s traditional businesses to AI infrastructure.
ASML raised its 2026 revenue guidance to €43-45 billion, up from €36-40 billion, after beating Q2 estimates on surging AI chipmaking demand, sending shares up 5.7% as the company plans a 30% capacity boost for its EUV systems over the next two years.
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…
Disclaimer: The content of this post is sourced from external sites and is for informational purposes only. All rights and…